抽象的
Percutaneous transcatheter pulmonary and tricuspid replacement in carcinoid heart disease.
Sheng Wang*
The most successful treatment for carcinoid heart disease is surgical valve replacement; however, reoperation for prosthetic valve failure has a high risk. In a patient with carcinoid heart disease, we present the first known percutaneous transcatheter pulmonary and tricuspid valve-in-valve replacement for bioprosthesis degeneration for any reason
免责声明: 此摘要通过人工智能工具翻译，尚未经过审核或验证。